In case you’ve been living under a rock, you already know that the recently discovered omicron variant of SARS-CoV-2 is spreading globally, and it could be somewhat resistant to the coronavirus vaccines on the market. That’s alarming enough on its own — and if you’re invested in some of the leading vaccine stocks, omicron potentially poses an additional concern.